Category: Acquisition News

Nissha Medical Technologies is excited to share the latest chapter in our journey toward medical innovation. Following a resolution from our Board of Directors on December 4, 2023, we formalized a definitive agreement to acquire the majority equity of Isometric Intermediate LLC., owner of the Isometric group of companies, an esteemed medical micro-molding company. The completion of this acquisition is scheduled to occur in late December following necessary filings. This strategic agreement aligns seamlessly with our mission to deliver high-quality, value added products in the global medical device market. Operating as a Contract Design/Development and Manufacturing Organization (CDMO), our comprehensive business model spans the design, development, and manufacturing of minimally invasive surgical instruments and medical wearables. Now, with Isometric's 30 years of expertise, specifically in micro-molding, we are poised to usher…

Exciting news! Nissha Medical Technologies (NMT) has successfully acquired Cardinal Health's Medical Chart Paper Business. Our commitment is to expand and optimize the Chart Paper portfolio while continuing to provide exceptional customer service and support. This acquisition includes the manufacturing and sale of Patient Monitoring Chart Paper for Cardiology and Fetal Monitoring that will enhance our existing comprehensive catalog, as well as the sale and distribution of Digital Imaging Media. Our retail products are available to private label for distributors and OEM’s, always ensuring superior quality solutions as a global med tech CDMO. NMT's Chart Paper ensures precise ECG and fetal monitor results that meets or exceeds industry standards. We offer a wide range of chart papers for various hospital departments, making procurement easy. Explore our comprehensive selection of medical…

Nissha Medical Technologies is thrilled to share that NMT has officially entered a capital and business partnership with EndoTheia, Inc. EndoTheia specializes in the design and development of endoscopic devices. They have introduced groundbreaking capabilities that enhance the maneuverability and precision of current endoscopic tools. Their patent portfolio provides the basis of technology that holds promise for improving patient outcomes when compared to conventional endoscopic devices and robotic platforms. This partnership between NMT and EndoTheia will offer significant innovation opportunities by leveraging both companies’ design and development engineering capabilities, and NMT’s extensive manufacturing capabilities. This technology will drive significant innovation in medical device OEM’s existing platforms by providing steering for mechanical devices through working channels of existing endoscopes and create new opportunities for steering technology in new devices not previously…